GV

GeezerVison

The World Wide Web, restored to 800 pixels of glory.

Home|About|Gaming cabinet|Archives|How it works|Starter sites

On this site

  • See why it’s faster →
  • Try Free Now →
  • Patients/Families
  • Providers
  • Partners
  • Products
  • Company
  • Customer Support
  • Order
  • Gene Browser
  • Gene Coverage Browser
  • Secondary Findings Guide
  • Grant Program
  • 3B-GENOME

This view

  • Original page
  • New address

GeezerVison is showing 3billion.io — Genetic testing for rare disease patients | 3billion

AI-powered
genetic testing

for rare disease diagnosis

Explore our tests
Scroll down
  • Seoul National University Hospital
  • CHA Bundang Medical Center
  • Hanyang University Seoul Hospital
  • Samsung Changwon Hospital
  • Jeju National University Hospital
  • AstraZeneca
  • Novartis
  • Neurologia Infantil
  • Research Institute of Environmental Medicine, Nagoya University
  • Hospital Kuala Lumpur
  • Instituto de Oftalmología
  • Clinic for Special Children
  • Federal University of São Paulo (UNIFESP)
  • National and Kapodistrian University of Athens
  • Loh Guan Lye Specialists Centre
  • Taibah University
  • CHU Farhat Hached Sousse
  • Singapore Eye Research Institute
  • University of Monastir
  • Federal University of Goiás
  • Kohat University of Science and Technology
  • Centre Hospitalier Universitaire Ibn Sina, Rabat
  • Tbilisi State Medical University

You're treating a patientwho has spent yearswithout a diagnosis.

You've tested for onesuspected condition afteranother, but still have noclear explanation for theirsymptoms.

Without a diagnosis, it'sdifficult to determine theright treatment.

Could a rare disease
be the answer?

Genetic testing
can help you find out.

From 100,000 to one.

  • EVIDENCEClassifies ~100,000 WES variants in 5 minutes on average.
    ACMG criteria · 98.4% sensitivity · 99.99% specificity
  • 3CnetAI predicts pathogenicity for variants lacking evidence.
    2.2× higher sensitivity, improving VUS reclassification.
  • 3ASCRanks candidate variants by symptom similarity.
    Causative variant in the top 5 in 96% of cases.
  • GeneticistsOur team confirms the final diagnosis.
    A report with classification evidence and interpretation.

What about patients
who
still don't have a diagnosis?

We keep reanalyzing
undiagnosed cases
until a diagnosis is found.

"Continuously revisiting data from undiagnosed patients — that's the real strength. Clinicians simply
don't have much time to chase every new paper or reinterpret variants themselves."

Explore reanalysis

Simple to order.
Precise in results.

Order in just a few steps.
We'll send the sample kit.

Place an order

We work alongside clinicians
around the world.

  • 70+

    Countries where testing
    is available

    View Detail
  • 2,200+

    Clinicians who have used
    our testing

    View Detail
  • 100,000+

    Patients who have received
    their test results

    View Detail
  • 12+

    Global pharma partners in
    precision prescribing

    View Detail
  • 138+

    Papers published from
    our ongoing research

    View Detail

Find the answer
together with
our
clinical genetics team.

Ask about results, request a VUS review, or share new symptoms for reinterpretation.

You are visitor 01402503 — GeezerVison does not store the pages you look up.
Best viewed with Netscape Navigator 4.7 or Internet Explorer 6 at 800×600. No cookies required.